Genfit (GNFT) News Today €5.40 +0.23 (+4.45%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Esker And Two High Growth Tech Stocks In FranceSeptember 24, 2024 | finance.yahoo.comBuy Rating Affirmed for Genfit SA on Financial Milestones and Promising Drug ApprovalsSeptember 20, 2024 | markets.businessinsider.comGENFIT S.A.: GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate UpdateSeptember 20, 2024 | finanznachrichten.deGENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate UpdateSeptember 19, 2024 | markets.businessinsider.comEuropean Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday TradingSeptember 11, 2024 | msn.comInnate Pharma (IPH)September 1, 2024 | investing.comGilead wins FDA nod for liver disease drugAugust 15, 2024 | msn.comPositive Outlook for Genfit SA with EU Approval Anticipated and Promising Pipeline DevelopmentsJuly 29, 2024 | markets.businessinsider.comEuropean Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%April 26, 2024 | msn.comBuy Rating Reiterated for Genfit SA Amidst Promising Clinical Developments and Strong Financial OutlookApril 8, 2024 | markets.businessinsider.comEuropean Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week LowerApril 5, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Genfit SA (GNFT) and Laboratory (LH)April 5, 2024 | markets.businessinsider.comEuropean Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday TradingFebruary 15, 2024 | msn.comGenfit (GNFTF) Gets a Buy from Kepler CapitalFebruary 14, 2024 | markets.businessinsider.comGenfit S.A. (GNFT.PA)January 20, 2024 | finance.yahoo.comGENFIT Announces 2024 Financial CalendarJanuary 15, 2024 | finance.yahoo.comBuy Rating Affirmed for Genfit SA Amid Favorable Regulatory Developments and Positive Trial ResultsDecember 11, 2023 | markets.businessinsider.comGENFIT Announces Publication in the Journal of Hepatology on the Accurate Performance of NIS2+™ as a Screening Tool for the Enrollment of Patients in MASH Clinical TrialsDecember 6, 2023 | finance.yahoo.comGENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023November 16, 2023 | finance.yahoo.comGenfit stock rallies 20% after hours on data for liver disease drugNovember 13, 2023 | msn.comKepler Capital Sticks to Its Buy Rating for Genfit (GNFTF)November 12, 2023 | markets.businessinsider.comGENFIT S.A.: GENFIT Reports Third Quarter 2023 Financial InformationNovember 10, 2023 | finanznachrichten.deGENFIT to Present Update on Scientific and Corporate Progress at The Liver Meeting® 2023November 2, 2023 | finance.yahoo.comEuropean Equities Traded in the US as American Depositary Receipts Rise in Wednesday TradingNovember 1, 2023 | msn.comUBS starts Cymabay at buy, expecting positive Phase 3 data for seladelparAugust 14, 2023 | msn.comGENFIT Announces the Publication of New Data on the Clinical Performance of NIS2+™ in Older Patients in Hepatology CommunicationsAugust 11, 2023 | finance.yahoo.comAnalyst Expectations for Genfit's FutureJuly 3, 2023 | markets.businessinsider.comGenfit gains as Phase 3 trial for liver disease candidate succeeds (update)June 30, 2023 | msn.comIpsen, GENFIT Reveal Positive Phase III Trial Results Of Elafibranor In Patients With PBCJune 30, 2023 | markets.businessinsider.comGenfit (EPA:GNFT) Price Target Decreased by 11.94% to 8.02June 4, 2023 | msn.comGENFIT: May 24, 2023 Combined Shareholders Meeting resultsMay 24, 2023 | finance.yahoo.comGENFIT S.A.: GENFIT Reports First Quarter 2023 Financial InformationMay 12, 2023 | finanznachrichten.deGenfit: Major Data Release Before End Of Q2 Of 2023 Could Get Ball RollingMay 11, 2023 | msn.comGENFIT Reports First Quarter 2023 Financial InformationMay 11, 2023 | finance.yahoo.comGENFIT Announces Publication of Extra-Financial Performance Report 2022April 27, 2023 | finance.yahoo.comEuropean Equities Move Modestly Higher in Friday Trading, But Set to End Week LowerApril 21, 2023 | msn.comEuropean Equities Nudge Higher in Tuesday Trading on Rising Bank, Pharma StocksApril 18, 2023 | msn.comGENFIT Announces Publication of the 2022 Universal Registration Document and the 2022 Annual Report on Form 20-FApril 18, 2023 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Kronos Bio (KRON), Genfit SA (GNFT) and Talaris Therapeutics (TALS)April 17, 2023 | markets.businessinsider.comGENFIT S.A.: GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate UpdateApril 14, 2023 | finanznachrichten.deGENFIT Reports Full-Year 2022 Financial Results and Provides Corporate UpdateApril 13, 2023 | finance.yahoo.comGENFIT Announces Revenues and Cash Position as of December 31, 2022March 1, 2023 | finance.yahoo.comFinancial, Pharma Gains Spur European Equities Higher in Tuesday TradingJanuary 3, 2023 | msn.comGenfit's Fatty Liver Drug Study Results Are Coming. Here's What You Need to Know.January 1, 2023 | thestreet.comGENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver DiseasesNovember 18, 2022 | technews.tmcnet.comGENFIT Reports Third Quarter 2022 Financial InformationNovember 10, 2022 | finance.yahoo.comEuropean ADRs Move Higher in Wednesday TradingOctober 27, 2022 | msn.comGNFT.O - Genfit SA (ADR) | Stock Price & Latest News | ReutersOctober 12, 2022 | reuters.comGNFT Genfit S.A.June 14, 2022 | seekingalpha.comGENFIT: May 25, 2022 Combined Shareholders Meeting resultsMay 25, 2022 | finance.yahoo.com Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFT and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here GNFT Media Mentions By Week GNFT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNFT News Sentiment▼0.000.41▲Average Medical News Sentiment GNFT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNFT Articles This Week▼00▲GNFT Articles Average Week Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Merck KGaA News MorphoSys News ad pepper media International News Medigene News Fielmann Group News Fresenius SE & Co. KGaA News Sanofi News Sartorius Stedim Biotech News Siemens Healthineers News Bayer Aktiengesellschaft News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (EPA:GNFT) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genfit S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genfit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
